Baxa Corp. recently announced the expansion of its Valimed System, which uses enhanced photoemission spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics to provide an increased level of patient safety.
ValiMed compares a medication's spectroscopic signature to the Medication Signature Library and returns a "validated" or "not validated" result, reportedly requiring no user interpretation.
July 2007